Acropolis Investment Management’s Blackstone BX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$245K Buy
2,189
+652
+42% +$85.3K 0.01% 264
2026
Q2
$181K Buy
1,537
+7
+0.5% +$841 0.01% 302
2026
Q1
$176K Buy
+1,530
New +$199K 0.01% 304
2025
Q2
– Sell
-905
Closed -$127K – 256
2025
Q1
$127K Buy
905
+3
+0.3% +$487 0.01% 276
2024
Q4
$156K Hold
902
– – 0.01% 262
2024
Q3
$138K Hold
902
– – 0.01% 268
2024
Q2
$112K Sell
902
-102
-10% -$12.6K 0.01% 276
2024
Q1
$132K Sell
1,004
-165
-14% -$20.6K 0.01% 259
2023
Q4
$153K Hold
1,169
– – 0.01% 242
2023
Q3
$125K Sell
1,169
-3
-0.3% -$312 0.01% 254
2023
Q2
$109K Buy
1,172
+2
+0.2% +$173 0.01% 249
2023
Q1
$103K Buy
+1,170
New +$103K 0.01% 251
2022
Q4
– Sell
-1,410
Closed -$118K – 247
2022
Q3
$118K Sell
1,410
-13
-0.9% -$1.26K 0.01% 222
2022
Q2
$130K Buy
1,423
+13
+0.9% +$1.4K 0.01% 218
2022
Q1
$179K Buy
1,410
+400
+40% +$48.8K 0.02% 190
2021
Q4
$131K Buy
+1,010
New +$135K 0.01% 220

Other funds holding BX

Acropolis Investment Management's BX Position: Q3 2026 in Review

Acropolis Investment Management increased its Blackstone (BX) stake by 42% in Q3 2026, buying an estimated $85.3K and bringing the position to 2,189 shares worth $245K. The position accounts for 0.01% of the portfolio, ranked #264.

Acropolis Investment Management first reported a position in BX in Q4 2021 and has held it in 16 quarters since. 98 funds tracked by Wall St. Rank hold BX as of Q3 2026.

  • Acropolis Investment Management held 2,189 shares of Blackstone worth $245K as of Q3 2026.
  • Acropolis Investment Management bought 652 Blackstone shares in Q3 2026, an estimated $85.3K.
  • Blackstone made up 0.01% of Acropolis Investment Management's portfolio in Q3 2026, its #264 holding.
  • Acropolis Investment Management first reported a position in Blackstone in Q4 2021 and has held it in 16 quarters since.
  • 98 funds tracked by Wall St. Rank held Blackstone as of Q3 2026.

Based on Acropolis Investment Management's 13F filing for Q3 2026, filed 8 Oct 2026.